Inteliview
Log inSign up
IPO Tracker
Scribe Therapeutics, Inc.

Scribe Therapeutics, Inc.

Scribe Therapeutics, Inc.

USPricing
Valuation$75M
Original Target2026-07-02 (Date under review)
Sector--
Exchange--
RELATED IPOS
Hyperliquid Strategies Inc
Hyperliquid Strategies IncHyperliquid Strategies IncUS · --
ConnectM Technology Solutions, Inc.
ConnectM Technology Solutions, Inc.ConnectM Technology Solutions, Inc.US · --
HCW Biologics Inc.
HCW Biologics Inc.HCW Biologics Inc.US · --
R
RanMarine Technology B.V.RanMarine Technology B.V.US · --
G
GridAI Technologies Corp.GridAI Technologies Corp.US · --
APEX Global Solutions Ltd
APEX Global Solutions LtdAPEX Global Solutions LtdUS · --
FAQ

When is the Scribe Therapeutics, Inc. IPO expected?

The Scribe Therapeutics, Inc. IPO is currently in the Pricing stage. The originally expected date was 2026-07-02 and the process is ongoing. Timelines may change based on market conditions.

What is Scribe Therapeutics, Inc.'s valuation?

Scribe Therapeutics, Inc.'s estimated valuation is approximately $75M. The final valuation will depend on IPO pricing and market demand.

Can retail investors participate in the Scribe Therapeutics, Inc. IPO?

U.S. IPOs are typically allocated to institutional investors first. Retail investors can purchase shares on NYSE/NASDAQ after listing. Some brokerages offer IPO access programs for pre-IPO allocation.